![]()
Ingredion Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ingredion (INGR)
PR Newswire
NEW YORK, Nov. 9, 2026
Ingredion’s third-quarter 2026 adjusted EPS came in below Wall Street consensus while revenue landed near estimates, and INGR shares fell on the report. Levi & Korsinsky is investigating potential securities law violations on behalf of investors who lost money.
NEW YORK, Nov. 9, 2026 /PRNewswire/ — An adjusted EPS miss against Wall Street consensus sent Ingredion Incorporated (NYSE: INGR) shares lower after the Company’s third-quarter 2026 report, in which adjusted EPS fell approximately 19% from the prior-year quarter. If you bought INGR shares and are now holding a loss, you are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
The gap was on the profit line. Third-quarter revenue came in broadly in line with consensus, and net sales slipped only about 1% to 1.3% year over year. Adjusted EPS missed analyst estimates. Adjusted operating income fell approximately 19% from the same quarter in 2025.
Ingredion tied the shortfall to softer demand in its U.S./Canada business and higher manufacturing and input costs. Sales held near expectations. Earnings did not — and INGR shareholders took the loss. Levi & Korsinsky is investigating potential securities law violations on behalf of affected Ingredion investors.
INGR shareholders who lost money on the third-quarter miss may request a free review of their INGR losses or call (212) 363-7500.
ABOUT THE FIRM — For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years.
Frequently Asked Questions About the INGR Investigation
Q: How much did INGR stock drop?A: Shares fell after Ingredion Incorporated (NYSE: INGR) reported third-quarter 2026 adjusted EPS below analyst estimates, with adjusted operating income and adjusted EPS down approximately 19% year over year. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation.
Q: When did Ingredion allegedly mislead investors?A: The investigation concerns statements made before Ingredion’s third-quarter 2026 earnings report that allegedly caused investors to purchase securities at inflated prices.
Q: What do INGR investors need to do right now?A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate?A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my INGR shares — can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought INGR and sold at a loss may still participate in the investigation.
Q: What if my INGR losses are small — is it still worth contacting a lawyer?A: Yes. There is no minimum loss amount required to participate in the investigation.
Q: What does it cost me to participate?A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ingredion-investigation-notice-levi–korsinsky-notifies-investors-of-pending-investigation-into-ingredion-ingr-302933774.html
SOURCE Levi & Korsinsky, LLP
